Han et al. found that METTL3 positively modulates pri-miR221/222 processing in an m6A-dependent manner by interacting with DGCR8, resulting in a reduction in the PTEN level, which ultimately results in proliferation of bladder cancer (29). The gene discussed is METTL3; the disease is urinary bladder carcinoma.